Title:
Amplifying NEOepitope specific Vaccine responses in progressive diffuse glioma - a randomized,open label,3arm multicenter Phase I trial to assess safety, tolerability and immunogenicity of IDH1R132H-specific peptide vaccine in combination with checkpoint inhibitor Avelumab
Phase:
I
Contact:
Sandy Walter / Study Nurse
Email-Address:
Sandy.Walter@med.uni-heidelberg.de
Clinical Investigator:
PD Dr. med. Antje Wick
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT03893903
EudraCT-Number:
Keine Registernummer angegeben.